Adarza Biosystems
Edit

Adarza Biosystems

https://adarzabio.com/
Last activity: 10.02.2021
Active
Categories: DiagnosticsLifeMedtechPlatformProductResearchScienceServiceTechnologyTools
The Arrayed Imaging Reflectometry (AIR) is a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid. Adarza delivers industry leading precision, accuracy, and robustness enabling highly multiplexed protein detection with high sensitivity and specificity. The company’s unique technology is flexible, data-rich, and easy to use, providing the only solution that spans the entire companion diagnostic life cycle from discovery to clinic, in both high-throughput core facilities as well as point of care (POC). Much like the first gene-chips enabled multiplexed genomics analysis, Adarza’s first-to-market high-multiplex and sensitivity antibody chips will fundamentally disrupt the field of proteomics research.
Followers
328
Followers
770
Mentions
15
Location: United States, Missouri, Maryland Heights
Employees: 11-50
Total raised: $28.8M
Founded date: 2008

Investors 5

Funding Rounds 3

DateSeriesAmountInvestors
23.01.2017Series C$17M-
22.03.2016Series B$5MCultivatio...
06.10.2014Series A$6.8M-

Mentions in press and media 15

DateTitleDescription
04.02.2020Adarza BioSystems Raises $25M Series D ST. LOUIS, MO, Biotech company Adarza BioSystems announced today that it has raised $25 million in a Series D round. >> Click here for more funding data on Adarza BioSystems >> To export Adarza BioSystems funding data to PDF...
23.01.2017Adarza BioSystems Closes $17M Series C FinancingAdarza BioSystems, Inc., a Rochester, N.Y. and St. Louis, Mo.-based developer and manufacturer of label-free biosensor assays and instruments servicing life science research, drug development and in vitro diagnostics customers, closed a $17...
23.01.2017Term Sheet — Monday, January 23Big Tech M&A Last year, the U.S. tech titans slowed their pace of acquisitions, but three companies bucked that trend: Google, Intel, and Salesforce. Of the three, Salesforce had the highest acceleration of deals. Last year the $53 bill...
23.01.2017Adarza BioSystems Raises $17M Series CAdarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in it...
23.01.2017Adarza BioSystems Raises $17M Series CAdarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in it...
19.01.2017Adarza raises $17M Series C to dial back the noiseAIR is designed to rapidly identify and quantify hundreds of target analytes, without chemical labels or complex processing steps. The technology manipulates the signal-to-noise ratio — how scientists typically find the proverbial needle in...
22.03.2016Adarza BioSystems Closes $5M Series B FinancingAdarza BioSystems, a West Henrietta, NY- and St. Peters, MO-based provider of label-free, multiplex assays, closed a $5m Series B financing. Backers included Cultivation Capital, Lewis and Clark Ventures and Siemens’ venture capital arm. Th...
22.03.2016Adarza BioSystems Receives $5M ROCHESTER, NY, Adarza BioSystems, a developer of label-free multiplex assays, has raised $5 million in Series B funding. >> Click here for more funding data on Adarza BioSystems >> To export Adarza BioSystems funding data to...
02.03.2015The Arch Angel Network: 10 Years, 59 InvestmentsLast year alone The Arch Angel Network invested nearly $10 million in local, St. Louis based startups, bringing the total number of investments the organization they’ve made in the last decade to over $50 million. They celebrated their tent...
24.11.2014Horizon Discovery Group plc and Adarza BioSystems enter supply & licensing agreementHorizon Discovery Group plc and Adarza BioSystems enter supply & licensing agreement 24-11-2014 Agreement gives Horizon exclusive right to supply services on Adarza’s multiplex label-free immunoassay technology. Cambridge, UK, and St. L...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In